In consistence with our results, Gaidzik et al. [89] reported dysregulation of the apoptotic pathway, supported in particular by an increase in BCL2L1 expression, as a key feature of RUNX1-mutated AML. Here, BCL2L1 is linked to acute myeloid leukemia.